Shuhang L. Liang
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Intraindividual comparison of 3-T and 5-T gadoxetic acid-enhanced MRI for evaluating HCC: initial findings.
Journal: Abdominal radiology (New York)
Published: December 04, 2025
Corrigendum to 'Tumor-derived CD109 orchestrates reprogramming of tumor-associated macrophages to dampen immune response' (J Hepatol 2025 [946-958]).
Journal: Journal of hepatology
Published: October 28, 2025
BCAT1 inhibits crotonate-related epigenetic modulation of metabolic genes in tumor-associated macrophages to counter immunosuppression.
Journal: Nature communications
Published: September 15, 2025
Gd-EOB-DTPA-Enhanced Magnetic Resonance Imaging for Predicting Immunotherapy Response in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Journal: Liver cancer
Published: August 02, 2025
Tumor-derived CD109 orchestrates reprogramming of tumor-associated macrophages to dampen immune response.
Journal: Journal of hepatology
Published: July 08, 2024
Cholangiocarcinoma PDHA1 succinylation suppresses macrophage antigen presentation via alpha-ketoglutaric acid accumulation.
Journal: Nature communications
Published: July 02, 2024
VCP downstream metabolite glycerol-3-phosphate (G3P) inhibits CD8+T cells function in the HCC microenvironment.
Journal: Signal transduction and targeted therapy
Published: June 29, 2024
Suppression of microRNA-320 Induces Cerebral Protection Against Ischemia/Reperfusion Injury by Targeting HMGB1/NF-kappaB Axis.
Journal: Physiological research
Published: March 11, 2024
Hepatocellular Carcinoma LINC01116 Outcompetes T Cells for Linoleic Acid and Accelerates Tumor Progression.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 18, 2024
A STT3A-dependent PD-L1 glycosylation modification mediated by GMPS drives tumor immune evasion in hepatocellular carcinoma.
Journal: Cell death and differentiation
Published: January 16, 2024
LncRNA PWRN1 inhibits the progression of hepatocellular carcinoma by activating PKM2 activity.
Journal: Cancer letters
Published: August 06, 2023
Acetylation-dependent regulation of core spliceosome modulates hepatocellular carcinoma cassette exons and sensitivity to PARP inhibitors.
Journal: Nature communications
Published: June 29, 2023
Last Updated: 09/26/2026